Código QR (código de barras bidimensional)

Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial

BackgroundAntihyperglycemic therapies may increase the risk of cardiovascular events including hospitalization for heart failure. There is a paucity of data evaluating the cardiovascular safety of antihyperglycemic therapies in the high‐risk period following an acute coronary syndrome (ACS). Methods...

ver descrição completa

Na minha lista:
Principais autores: Abhinav Sharma, Christopher P. Cannon, William B. White, Yuyin Liu, George L. Bakris, William C. Cushman, Faiez Zannad
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2018-06-01
coleção:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:
acute coronary syndrome
alogliptin
dipeptidyl dipeptidase‐4 inhibitor
diabetes mellitus
medical therapy
medication
Acesso em linha:https://www.ahajournals.org/doi/10.1161/JAHA.117.007649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados